UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000053274
Receipt number R000060802
Scientific Title The efficacy of modified Thoracoabdominal nerves blocks through perichondrial approach (M-TAPA) and External Oblique Intercostal block (EOIB) in laparoscopic cholecystectomy: single-blind randomized controlled trial
Date of disclosure of the study information 2024/01/15
Last modified on 2024/01/05 16:18:10

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The efficacy of modified Thoracoabdominal nerves blocks through perichondrial approach (M-TAPA) and External Oblique Intercostal block (EOIB) in laparoscopic cholecystectomy: single-blind randomized controlled trial

Acronym

The efficacy of modified Thoracoabdominal nerves blocks through perichondrial approach (M-TAPA) and External Oblique Intercostal block (EOIB) in laparoscopic cholecystectomy: single-blind randomized controlled trial

Scientific Title

The efficacy of modified Thoracoabdominal nerves blocks through perichondrial approach (M-TAPA) and External Oblique Intercostal block (EOIB) in laparoscopic cholecystectomy: single-blind randomized controlled trial

Scientific Title:Acronym

The efficacy of modified Thoracoabdominal nerves blocks through perichondrial approach (M-TAPA) and External Oblique Intercostal block (EOIB) in laparoscopic cholecystectomy: single-blind randomized controlled trial

Region

Japan


Condition

Condition

laparoscopic cholecystectomy

Classification by specialty

Anesthesiology Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to prospectively compare and evaluate whether M-TAPA and EOIB can be substituted for transversus abdominis plane (TAP) block as a perioperative analgesic technique for laparoscopic cholecystectomy.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The primary outcome of the study was to evaluate the numerical rating scale (NRS) score at rest and during movement in the first postoperative 0, 1, 6, 12, and 24 hours in patients with TAPB, M-TAPA, or EOIB.

Key secondary outcomes

Secondary endpoints were postoperative narcotic consumption, evaluating the postoperative patient-completed QoR-15 questionnaire, the incidence of nausea and vomiting(PONV), and incidence of complications during nerve block techniques.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -investigator(s) and assessor(s) are blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

TAP block was administered bilaterally after the induction of anesthesia before the surgical procedures.

Interventions/Control_2

M-TAPA was administered bilaterally after the induction of anesthesia before the surgical procedures.

Interventions/Control_3

EOIB was administered bilaterally after the induction of anesthesia before the surgical procedures.

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

This prospective, single-blind, randomized controlled study was conducted from December 2022 to September 2023 at single center. After providing written informed consent, patients with American Society Anesthesiologists (ASA) physical status clasification scores of I or II were included in this study.

Key exclusion criteria

The exclusion criteria were known allergy to local anesthetics, body mass index(BMI) >35 kg/m2 or <17 kg/m2, advanced liver or kidney failure,history of trauma, stroke or cognitive impairment, and chronic analgesic drugs use.

Target sample size

45


Research contact person

Name of lead principal investigator

1st name Hideki
Middle name
Last name Matsuura

Organization

Nara medical university

Division name

Department of anesthesiology

Zip code

634-8522

Address

840 Shijo-cho, Kashihara, Nara 634-8522, Japan

TEL

+81-744-29-8902

Email

hmatsura0610@naramed-u.ac.jp


Public contact

Name of contact person

1st name Hideki
Middle name
Last name Matsuura

Organization

Nara medical university

Division name

Department of anesthesiology

Zip code

634-8522

Address

840 Shijo-cho, Kashihara, Nara 634-8522, Japan

TEL

+81-744-29-8902

Homepage URL


Email

hmatsura0610@naramed-u.ac.jp


Sponsor or person

Institute

Nara medical university

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Otemae Hospital

Address

1-5-34 Otemae Chuo-ku, Osaka, 540-0008, Japan

Tel

+81-6-6941-0484

Email

hmatsura0610@naramed-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 01 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

48

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2022 Year 11 Month 16 Day

Date of IRB

2022 Year 11 Month 16 Day

Anticipated trial start date

2022 Year 12 Month 14 Day

Last follow-up date

2023 Year 09 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 01 Month 05 Day

Last modified on

2024 Year 01 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000060802